Introduction
Imaging Assessment
Angiography and embolization
Indications
Access
Angiographic technique
Embolization technique
Embolic agents
Results and outcome
References | P# | Angio | Embol. | T.S. | C.S. | Mortal. | Repeat | Compl | OM | PRM |
---|---|---|---|---|---|---|---|---|---|---|
Agolini [8] | 806 | 35 (4.3%) | 15 (43%) | 15 (100%) | 100% | 7/15 (47%) | 0 | NA | 74/806 (9.2%) | 0 |
Wong [9] | 507 | 22 (4.3%) | 17 (77%) | 17 (100%) | 100% | 3/17 (17.6%) | 0 | 0 | NA | 0 |
Velmahos [12] | 100 | 100 (100%) | 80 (80%) | 95% | NA | 2 (14%) | 4 (5%) | 5 (6.3%) | NA | 0 |
Cook [6] | 150 | 23 (15%) | 18 (78%) | 18 (100%) | 16 (89%) | 10/18 (56%) | NA | 2 (11%) | 33/77 (43%) | 0 |
Hagiwara [14] | 234 | 81 (35%) | 61 (75%) | NA | NA | 13/61 (21%) | NA | NA | 13/234 (5.6%) | NA |
Kimbrell [11] | 1017 | 92 (9%) | 55 (60%) | 55 (100%) | NA | 10/55 (18%) | 7/55 (13%) | 4/55 (7.3%) | 14/92 (15%) | NA |
Shapiro [43] | 678 | 31 (4.6%) | 16 (52%) |
17/20 (85%)
| NA | 2/16 (13%) | 7/31 (23%) | NA | 66/678 (9.7%) | NA |
Fangio [34] | 311 | 32 (10.3%) | 25 (78%) |
24/25 (96%)
| 21 (84%) | 9/25 (36%) | 0 | 1 (4%) | 10/32 (31%) | NA |
Totterman [10] | 1260 | 46 (3.7%) | 31 (67%) | 29/31 (94%) | 29/31 (94%) | 5/31 (16%) | 3/31 (9.7%) | 0 | NA | 0 |
Verbeek [37] | 217 | 58 (26.7%) | 48 (83%) | 46/48 (96%) | 46/48 (96%) | 2/48 (4.2%) | 5/58 (8.6%) | NA | 69/217 (32%) | 2/48 |
Salim [55] | 603 | 137 (23%) | 85 (62%) | 85/85 (100%) | NA | 10/85 (11.8%) | NA | 1 (1.2%) | 54/603 (9%) | NA |
Osborn [44] | 20 | 20 (100%) | 13 (65%) | NA | NA | NA | NA | NA | 6/20 (30%) | 2 |
Fang [13] | 964 | 174 (18%) | 140 (80%) | 140/140 (100%) | NA | 26/140 (18.6%) | 26/140 (18.6%) | 0 | NA | 12 |
Jeske [15] | 1476 | 42 (2.8%) | 41 (98%) | 41/42 (98%) | NA | 13/41 (31.7%) | 3/41 (7.3%) | 10 (24%) | NA | 0 |
Hauschild [3] | 152 | 17 (11.2%) | 17 (100%) | 17/17 (100%) | 17 (100%) | 3/17 (17.6%) | 0 | 6 (35%) | NA | 0 |
Tanizaki [46] | 140 | 68 (49%) | 68 (100%) | NA | NA | 12/68 (17.6%) | 0 | 0 | NA | 1 |
Ierardi [41] | 168 | NA | 160 | 160 (100%) | 133 (95%) | 15 (9.4%) | 3 (1.9%) | 0 | NA | 7 |
Lustenberger [16] | 173 | 16 (9.2%) | 16 (100%) | 16 (100%) | 16 (100%) | 4/16 (25%) | NA | 0 | NA | 0 |